Search research articles
Contact Us
Filters
Showing results (1-10 of 56) with videos related to
Page
of 6
Sort By:
Mini Reviews in Medicinal Chemistry
|
July 20, 2005
Computational chemistry as an integral component of lead generation
Olivier Roche, Wolfgang Guba
Current Opinion in Drug Discovery & Development
|
April 23, 2008
Recent developments in de novo design and scaffold hopping
Harald Mauser, Wolfgang Guba
Drug Discovery Today
|
April 4, 2006
Integrating molecular design resources within modern drug discovery research: the Roche experience
Martin Stahl, Wolfgang Guba, Manfred Kansy
Bioorganic & Medicinal Chemistry Letters
|
March 5, 2005
Novel and potent NPY5 receptor antagonists derived from virtual screening and iterative parallel chemistry design
Wolfgang Guba, Werner Neidhart, Matthias Nettekoven
Journal of Chemical Information and Modeling
|
December 19, 2015
Torsion Library Reloaded: A New Version of Expert-Derived SMARTS Rules for Assessing Conformations of Small Molecules
Wolfgang Guba, Agnes Meyder, Matthias Rarey, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
September 24, 2022
Machine Learning and Computational Chemistry for the Endocannabinoid System
Kenneth Atz, Wolfgang Guba, Uwe Grether, et al.
Proteins
|
October 15, 2005
Focused library design in GPCR projects on the example of 5-HT(2c) agonists: comparison of structure-based virtual screening with ligand-based search methods
Caterina Bissantz, Claire Schalon, Wolfgang Guba, et al.
Journal of Chemical Information and Modeling
|
June 8, 2012
TFD: Torsion Fingerprints as a new measure to compare small molecule conformations
Tanja Schulz-Gasch, Christin Schärfer, Wolfgang Guba, et al.
ACS Omega
|
January 23, 2023
Tritium Labeling of Neuromedin S by Conjugation with [<sup>3</sup>H]<i>N</i>-Succinimidyl Propionate
Martin R Edelmann, Johannes Erny, Wolfgang Guba, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 20, 2004
Comparison of inhibitory activity of isomeric triazolopyridine derivatives towards adenosine receptor subtypes or do similar structures reveal similar bioactivities?
Wolfgang Guba, Matthias Nettekoven, Bernd Püllmann, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 56) with videos related to
Sort By:
Page
of 6
Mini Reviews in Medicinal Chemistry
|
July 20, 2005
Computational chemistry as an integral component of lead generation
Olivier Roche, Wolfgang Guba
Current Opinion in Drug Discovery & Development
|
April 23, 2008
Recent developments in de novo design and scaffold hopping
Harald Mauser, Wolfgang Guba
Drug Discovery Today
|
April 4, 2006
Integrating molecular design resources within modern drug discovery research: the Roche experience
Martin Stahl, Wolfgang Guba, Manfred Kansy
Bioorganic & Medicinal Chemistry Letters
|
March 5, 2005
Novel and potent NPY5 receptor antagonists derived from virtual screening and iterative parallel chemistry design
Wolfgang Guba, Werner Neidhart, Matthias Nettekoven
Journal of Chemical Information and Modeling
|
December 19, 2015
Torsion Library Reloaded: A New Version of Expert-Derived SMARTS Rules for Assessing Conformations of Small Molecules
Wolfgang Guba, Agnes Meyder, Matthias Rarey, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
September 24, 2022
Machine Learning and Computational Chemistry for the Endocannabinoid System
Kenneth Atz, Wolfgang Guba, Uwe Grether, et al.
Proteins
|
October 15, 2005
Focused library design in GPCR projects on the example of 5-HT(2c) agonists: comparison of structure-based virtual screening with ligand-based search methods
Caterina Bissantz, Claire Schalon, Wolfgang Guba, et al.
Journal of Chemical Information and Modeling
|
June 8, 2012
TFD: Torsion Fingerprints as a new measure to compare small molecule conformations
Tanja Schulz-Gasch, Christin Schärfer, Wolfgang Guba, et al.
ACS Omega
|
January 23, 2023
Tritium Labeling of Neuromedin S by Conjugation with [<sup>3</sup>H]<i>N</i>-Succinimidyl Propionate
Martin R Edelmann, Johannes Erny, Wolfgang Guba, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 20, 2004
Comparison of inhibitory activity of isomeric triazolopyridine derivatives towards adenosine receptor subtypes or do similar structures reveal similar bioactivities?
Wolfgang Guba, Matthias Nettekoven, Bernd Püllmann, et al.
Page
of 6